![Jennifer Hodge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Jennifer Hodge
Anciens postes connus de Jennifer Hodge
Sociétés | Poste | Début | Fin |
---|---|---|---|
Nile Therapeutics, Inc. /Old/ | Corporate Officer/Principal | 17/06/1996 | 11/10/2007 |
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Corporate Officer/Principal | 01/01/2000 | 01/01/2007 |
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Corporate Officer/Principal | 29/04/2010 | - |
CAPRICOR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2007 | - |
Formation de Jennifer Hodge
The University of Edinburgh | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Royaume-Uni | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CAPRICOR THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Nile Therapeutics, Inc. /Old/ | Health Technology |
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Bourse
- Insiders
- Jennifer Hodge
- Expérience